's stock had its "buy" rating reissued by investment analysts at Maxim Group in a note issued to investors on Sunday. They currently have a $14.00 target price on the stock.
http://ift.tt/1a6Qy7N
http://ift.tt/1a6Qy7N
Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
No comments:
Post a Comment